Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Visualization of the binding between gintonin, a Panax ginseng-derived LPA receptor ligand, and the LPA receptor subtypes and transactivation of the EGF receptor

  • Choi, Sun-Hye (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine, Konkuk University) ;
  • Lee, Ra Mi (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine, Konkuk University) ;
  • Cho, Han-Sung (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine, Konkuk University) ;
  • Hwang, Sung Hee (Department of Pharmaceutical Engineering, College of Health Sciences, Sangji University) ;
  • Hwang, Hong-Ik (Center for Neuroscience, Korea Institute of Science and Technology) ;
  • Rhim, Hyewhon (Center for Neuroscience, Korea Institute of Science and Technology) ;
  • Kim, Hyoung-Chun (Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University) ;
  • Kim, Do-Geun (Dementia Research Group, Korea Brain Research Institute) ;
  • Cho, Ik-Hyun (Department of Science in Korean Medicine, Brain Korea 21 Plus Program, Department of Conversions Medical Science, Graduate School, Kyung Hee University) ;
  • Nah, Seung-Yeol (Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine, Konkuk University)
  • Received : 2021.07.21
  • Accepted : 2021.10.14
  • Published : 2022.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Gintonin is a ginseng-derived exogenous G-protein-coupled lysophosphatidic acid (LPA) receptor ligand. Gintonin exerts its neuronal and non-neuronal in vitro and in vivo effects through LPA receptor subtypes. However, it is unknown whether gintonin can bind to the plasma membrane of cells and can transactivate the epidermal growth factor (EGF) receptor. In the present study, we examined whether gintonin-biotin conjugates directly bound to LPA receptors and transactivated the EGF receptor. Methods: We designed gintonin-biotin conjugates through gintonin biotinylation and examined whether gintonin-biotin conjugate binding sites co-localized with the LPA receptor subtype binding sites. We further examined whether gintonin-biotin transactivated the EGF receptor via LPA receptor regulation via phosphor-EGF and cell migration assays. Results: Gintonin-biotin conjugates elicit [Ca2+]i transient similar to that observed with unbiotinylated gintonin in cultured PC3 cells, suggesting that biotinylation does not affect physiological activity of gintonin. We proved that gintonin-biotin conjugate binding sites co-localized with the LPA1/6 receptor binding sites. Gintonin-biotin binding to the LPA1 receptor transactivates the epidermal growth factor (EGF) receptor through phosphorylation, while the LPA1/3 receptor antagonist, Ki16425, blocked phosphorylation of the EGF receptor. Additionally, an EGF receptor inhibitor AG1478 blocked gintonin-biotin conjugate-mediated cell migration. Conclusions: We observed the binding between ginseng-derived gintonin and the plasma membrane target proteins corresponding to the LPA1/6 receptor subtypes. Moreover, gintonin transactivated EGF receptors via LPA receptor regulation. Our results suggest that gintonin directly binds to the LPA receptor subtypes and transactivates the EGF receptor. It may explain the molecular basis of ginseng physiology/pharmacology in biological systems.

Keywords

Acknowledgement

This work was supported by the Konkuk Univeristy in 2020.

References

  1. Nuri TH, Yee JC, Gupta M, et al. A review of Panax ginseng as an herbal medicine. Arch Pharm Pract 2016;7:61-5. https://doi.org/10.4103/2045-080X.183030
  2. Cho Yeon-Jin, Choi Sun-Hye, Lee Rami, Hwang Hongik, Rhim Hyewhon, Cho Ik-Hyun, Kim Hyoung-Chun, Lee Jeong-Ik, Hwang Sung-Hee, Nah Seung-Yeol. Ginseng gintonin contains ligands for GPR40 and GPR55. Molecules 2020;25:1102. https://doi.org/10.3390/molecules25051102
  3. Hwang SH, Shin TJ, Choi SH, et al. Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity. Mol Cell 2012;33:151-62. https://doi.org/10.1007/s10059-012-2216-z
  4. Pyo MK, Choi SH, Hwang SH, et al. Novel glycolipoproteins from ginseng. J Ginseng Res 2011;35:92-103. https://doi.org/10.5142/jgr.2011.35.1.092
  5. Nah SY. Gintonin: a novel ginseng-derived ligand that targets G protein-coupled lysophosphatidic acid receptors. Curr Drug Targets 2012;13:1659-64. https://doi.org/10.2174/138945012803529947
  6. Zhao Y, He D, Saatian B, Watkins T, Spannhake EW, Pyne NJ, Natarajan V. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases. J Biol Chem 2006;281:19501-11. https://doi.org/10.1074/jbc.M511224200
  7. Du Y, Zhang S, Yu H, Wu Y, Cao N, Wang W, Xu W, Li Y, Liu H. Autoantibodies against β1-Adrenoceptor exaggerated ventricular remodeling by inhibiting CTRP9 expression. J Am Heart Assoc 2019;8:e010475. https://doi.org/10.1161/jaha.118.010475
  8. Pazos Y, Alvarez CJ, Camina JP, Casanueva FF. Lysophosphatidic acid inhibits ghrelin secretion in the human gastric adenocarcinoma AGS cell line: role of mitogenic activated protein kinase signaling pathway. FEBS J 2007;274:5714-26. https://doi.org/10.1111/j.1742-4658.2007.06091.x
  9. Contos JJ, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol 2000;58:1188-96. https://doi.org/10.1124/mol.58.6.1188.
  10. Longmuir KJ, Martin OC, Pagano RE. Synthesis of fluorescent and radiolabeled analogues of phosphatidic acid. Chem Phys Lipids 1985;36:197-207. https://doi.org/10.1016/0009-3084(85)90001-5
  11. Salous AK, Panchatcharam M, Sunkara M, Mueller P, Dong A, Wang Y, Graf GA, Smyth SS, Morris AJ. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J Lipid Res 2013;54:2775-84. https://doi.org/10.1194/jlr.M039685
  12. Choi SH, Jung SW, Lee BH, et al. Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions. Front Pharmacol 2015;6:245. https://doi.org/10.3389/fphar.2015.00245
  13. Nam SM, Hwang H, Seo M, Chang BJ, Kim HJ, Choi SH, Rhim H, Kim HC, Cho IH, Nah SY. Gintonin attenuates D-galactose-induced hippocampal senescence by improving long-term hippocampal potentiation, neurogenesis, and cognitive functions. Gerontology 2018;64:562-75. https://doi.org/10.1159/000491113
  14. Kim H, Lee BH, Choi SH, Kim HJ, Jung SW, Hwang SH, Rhim H, Kim HC, Cho IH, Nah SY. Gintonin stimulates gliotransmitter release in cortical primary astrocytes. Neurosci Lett 2015;603:19-24. https://doi.org/10.1016/j.neulet.2015.07.012
  15. Hwang SH, Lee BH, Choi SH, Kim HJ, Jung SW, Kim HS, Shin HC, Park HJ, Park KH, Lee MK, Nah SY. Gintonin, a novel ginseng-derived lysophosphatidic acid receptor ligand, stimulates neurotransmitter release. Neurosci Lett 2015;584:356-61. https://doi.org/10.1016/j.neulet.2014.11.007
  16. Choi SH, Shin TJ, Lee BH, Hwang SH, Kang J, Kim HJ, Park CW, Nah SY. An edible gintonin preparation from ginseng. J Ginseng Res 2011;35:471-8. https://doi.org/10.5142/jgr.2011.35.4.471
  17. Choi SH, Hong MK, Kim HJ, Ryoo N, Rhim H, Nah SY, Kang LW. Structure of ginseng major latex-like protein 151 and its proposed lysophosphatidic acidbinding mechanism. Acta Crystallogr D Biol Crystallogr 2015;71:1039-50. https://doi.org/10.1107/S139900471500259X
  18. Choi SH, Jung SW, Kim HS, Kim HJ, Lee BH, Kim JY, Kim JH, Hwang SH, Rhim H, Kim HC, Nah SY. A brief method for preparation of gintonin-enriched fraction from ginseng. J Ginseng Res 2015;39:398-405. https://doi.org/10.1016/j.jgr.2015.05.002
  19. Hao F, Tan M, Xu X, Han J, Miller DD, Tigyi G, Cui MZ. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. Biochim Biophys Acta 2007;1771:883-92. https://doi.org/10.1016/j.bbalip.2007.04.010
  20. David M, Sahay D, Mege F, Descotes F, Leblanc R, Ribeiro J, Clezardin P, Peyruchaud O. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers. PLoS One 2014;9:e97771. https://doi.org/10.1371/journal.pone.0097771
  21. Lin YC, Huang YL, Lee H. Lysophosphatidic acid in prostate cancer progression. Transl Cancer Res 2015;4:527-36.
  22. Avendano-Vazquez SE, Garcia-Caballero A, Garcia-Sainz JA. Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1. Biochem J 2005;385:677-84. https://doi.org/10.1042/BJ20040891
  23. Alcantara-Hern andez R, Hernandez-M endez A, Campos-Martinez GA, Meizoso-Huesca A, Garcia-Sainz JA. Phosphorylation and internalization of lysophosphatidic acid receptors LPA1, LPA2, and LPA3. PLoS One 2015;10:e0140583. https://doi.org/10.1371/journal.pone.0140583
  24. Romano R, Bucci C. Role of EGFR in the nervous system. Cells 2020;9:1887. https://doi.org/10.3390/cells9081887
  25. Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers 2017;9:52. https://doi.org/10.3390/cancers9050052
  26. Ohnishi Y, Yasui H, Kakudo K, Nozaki M. Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells. Oncol Lett 2017;13:930-6. https://doi.org/10.3892/ol.2016.5500
  27. Schelch K, Vogel L, Schneller A, Brankovic J, Mohr T, Mayer RL, Slany A, Gerner C, Grusch M. EGF induces migration independent of EMT or invasion in A549 lung adenocarcinoma cells. Front Cell Dev Biol 2021;9:634371. https://doi.org/10.3389/fcell.2021.634371